$17.40
+0.270 (+1.58%)
At Close: Jun 03, 2026
Shareholders of Zenas BioPharma, Inc. Should Contact The Gross Law Firm Before June 16, 2025 to Discuss Your Rights - ZBIO
05:45am, Thursday, 29'th May 2025
NEW YORK , May 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zenas BioPharma, Inc. (NASDAQ: ZBIO). Shareholders who purchased shares of ZBIO during the cla
Investors in Zenas BioPharma, Inc. (ZBIO): Protect Your Rights - Contact Levi & Korsinsky Before June 16, 2025
04:30pm, Wednesday, 28'th May 2025
NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed a
NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ:ZBIO) pursuant and/or
Class Action Alert: Levi & Korsinsky Reminds Zenas BioPharma, Inc. (ZBIO) Investors of June 16, 2025 Deadline
02:25pm, Wednesday, 28'th May 2025
NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities
June 16, 2025 Deadline Approaching: Join Class Action Against Zenas BioPharma, Inc. (ZBIO) - Contact Levi & Korsinsky
11:45am, Wednesday, 28'th May 2025
NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
11:25am, Wednesday, 28'th May 2025
LOS ANGELES , May 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Zenas BioPharma, Inc. ("Zenas
ZBIO ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Zenas BioPharma, Inc. - June 16, 2025 Deadline
10:00am, Wednesday, 28'th May 2025
NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities
Shareholders of Zenas BioPharma, Inc. (ZBIO): Protect Your Rights Before June 16, 2025 - Contact Levi & Korsinsky
02:40pm, Tuesday, 27'th May 2025
NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities
Zenas BioPharma, Inc. (ZBIO) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before June 16, 2025
02:00pm, Tuesday, 27'th May 2025
NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities
NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc.(NASDAQ:ZBIO) pursuant and/or
Lost Money on Zenas BioPharma, Inc. (ZBIO)? Contact Levi & Korsinsky Before June 16, 2025 to Join Class Action
12:45pm, Tuesday, 27'th May 2025
NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities
Class Action Filed Against Zenas BioPharma, Inc. (ZBIO) Over Securities Violations - Contact Levi & Korsinsky Today
10:35am, Tuesday, 27'th May 2025
NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities
NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ:ZBIO). Such investor
SAN DIEGO , May 27, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas B
Sign In
Buy ZBIO